AKAM
40
-22
FRT
48
5
PM
56
6
GPC
37
2
BF.B
25
-3
XRAY
29
3
VFC
62
-3
ESS
65
5
NEE
50
4
SWKS
39
-6
RF
66
3
AMGN
47
3
T
45
4
SYK
64
2
VTR
50
3
EBAY
47
2
EIX
69
7
VRSK
84
9
GWW
78
2
AAP
30
-3
AKAM
40
-22
FRT
48
5
PM
56
6
GPC
37
2
BF.B
25
-3
XRAY
29
3
VFC
62
-3
ESS
65
5
NEE
50
4
SWKS
39
-6
RF
66
3
AMGN
47
3
T
45
4
SYK
64
2
VTR
50
3
EBAY
47
2
EIX
69
7
VRSK
84
9
GWW
78
2
AAP
30
-3
Financhill
Back

Vision Marine Technologies Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell
12

VMAR
Vision Marine Technologies

Last Price:
3.39
Seasonality Move:
-32.94%
Buy
100

RYTM
Rhythm Pharmaceuticals

Last Price:
67.31
Seasonality Move:
9.98%
Sell
12
Vision Marine Technologies (VMAR) is a Sell

Is Vision Marine Technologies a Buy, Sell or Hold?

  • The current Vision Marine Technologies [VMAR] share price is $3.37. The Score for VMAR is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • VMAR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
100
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

VMAR Stock Price Chart

What is Vision Marine Technologies's stock price today?

  • The Vision Marine Technologies share price today is $3.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VMAR is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $67.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.

VMAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.23 Buy
Relative Strength Index (14 RSI): 31.41 Sell
Chaikin Money Flow: -15268647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.77 - 4.29) Sell
Bollinger Bands (100): (0.13 - 3.07) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.14 Buy
Relative Strength Index (14 RSI): 81.29 Buy
Chaikin Money Flow: 966983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.36 - 56.78) Buy
Bollinger Bands (100): (43.87 - 52.87) Buy

VMAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.26 Buy
20-day SMA: 3.65 Sell
50-day SMA: 2.34 Buy
200-day SMA: 1.14 Buy
8-day EMA: 3.3 Buy
20-day EMA: 3.24 Buy
50-day EMA: 2.61 Buy
200-day EMA: 1.7 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.18 Buy
20-day SMA: 52.43 Buy
50-day SMA: 50.91 Buy
200-day SMA: 45.07 Buy
8-day EMA: 58.59 Buy
20-day EMA: 54.14 Buy
50-day EMA: 51.2 Buy
200-day EMA: 44.61 Buy

Vision Marine Technologies Earnings Growth & VMAR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $75.30 per share, and a decrease next year of $20.50 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.

Vision Marine Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):